Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Acta Pharmaceutica Sinica ; (12): 197-200, 2007.
Artigo em Chinês | WPRIM | ID: wpr-281942

RESUMO

Double antibody sandwich-type ELISA was used to detect rhG-CSF in serum to study the pharmacokinetics of rhG-CSF, PEG-rhG-CSF and rHSA-hG-CSF in mice and to confirm that PEGlyation and albumin fusion of rhG-CSF technology can prolong half-life of G-CSF. Pharmacokinetic parameters were calculated with 3P87 software. T1/2 s of rhG-CSF, PEG-rhG-CSF and rHSA-hG-CSF are 2. 1 , 14.2 and 10. 6 h, respectively. T1/2 s of PEG- rhG-CSF and rHSA-hG-CSF are 7, 5 times than T1/2 s of rhG-CSF, respectively. Tpeak s of PEG-rhG-CSF and rHSA-hG-CSF are 15, 13 times than Tpeak of rhG-CSF, respectively. The result of ELISA indicates that PEGlyation and albumin fusion of rhG-CSF technology can prolong half-life of G-CSF.


Assuntos
Animais , Humanos , Masculino , Camundongos , Área Sob a Curva , Ensaio de Imunoadsorção Enzimática , Métodos , Fator Estimulador de Colônias de Granulócitos , Sangue , Química , Farmacocinética , Meia-Vida , Camundongos Endogâmicos ICR , Polietilenoglicóis , Química , Proteínas Recombinantes de Fusão , Sangue , Química , Farmacocinética , Proteínas Recombinantes , Albumina Sérica , Química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA